About Contact Us Careers

Artificial Intelligence (AI) in Medical Writing Market Size and Forecast, by Type (Clinical writing, Regulatory writing, Patient documentation, Scientific writing); Deployment Mode; End use - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 6614
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Artificial Intelligence in Medical Writing Market Outlook:

Artificial Intelligence in Medical Writing Market size was over USD 878.08 million in 2025 and is anticipated to cross USD 2.78 billion by 2035, witnessing more than 12.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of artificial intelligence in medical writing is assessed at USD 974.49 million.

AI in Medical Writing Market overview
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The increasing complexity of healthcare data, the need for faster drug approvals, and the rise in clinical trials are key factors fueling the adoption of AI in medical writing. Technologies, such as NLP, and machine learning are helping reduce human error, improve accuracy, and streamline workflows, particularly in the pharmaceutical and healthcare sectors.

Moreover, regulatory authorities in various regions are starting to accept AI-generated documents, further accelerating the AI in medical writing market growth. In the upcoming years, AI is expected to advance further in automating not just routine writing tasks but also predictive analytics in clinical research. In June 2023, Amazon Web Services, Inc. announced a new HIPAA-eligible service, AWS HealthScribe with generative AI capabilities for natural language processing solutions. Such activities are projected to further boost the artificial intelligence (AI) in medical writing market expansion globally. 

Key AI in Medical Writing Market Insights Summary:

  • Regional Highlights:

    • North America artificial intelligence (AI) in medical writing market will account for 39.20% share by 2035, driven by the region’s strong healthcare infrastructure, substantial R&D investments, and regulatory demands for accurate and timely medical documentation.
    • Asia Pacific market will grow rapidly during the forecast period 2026-2035, fueled by advancements in healthcare technology and a rise in demand for personalized medicine and electronic health records (EHRs).

  • Segment Insights:

    • The cloud-based segment in the artificial intelligence in medical writing market is set for significant growth till 2035, fueled by scalability, cost-effectiveness, and ease of access.
    • The pharmaceutical & biotechnology companies segment in the artificial intelligence in medical writing market is forecasted to achieve a considerable share by 2035, influenced by high demand for efficient clinical trial documentation and regulatory submissions.

  • Key Growth Trends:

    • Shortage of skilled medical writers
    • Growing volume of medical data

  • Major Challenges:

    • Data privacy and security concerns

  • Key Players: IBM Corporation, Google LLC, Microsoft Corporation, OpenAI, Inc., Linguamatics (IQVIA), Nuance Communications, Inc. (Microsoft), Health Fidelity (Edifecs), Clinithink Ltd., Saama Technologies, Inc., Narrative Science (Tableau/Salesforce).

Global AI in Medical Writing Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 878.08 million
    • 2026 Market Size: USD 974.49 million
    • Projected Market Size: USD 2.78 billion by 2035
    • Growth Forecasts: 12.2% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (39.2% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, United Kingdom, Germany, Japan
    • Emerging Countries: China, India, Japan, South Korea, Singapore

    • Last updated on : 18 September, 2025

Growth Drivers

  • Shortage of skilled medical writers: With a limited number of medical professionals available to meet growing documentation demands, especially for regulatory and clinical trial purposes, AI tools are being increasingly adopted to bridge the gap. These tools enable faster and more accurate content generation, helping healthcare and pharmaceutical companies keep up with regulatory requirements despite workforce constraints. In March 2024, Indegene acquired Trilogy Writing & Consulting GmbH to support Indegene’s capabilities in clinical and regulatory writing. Such artificial intelligence (AI) in medical writing market activities owing to the shortage of labor are projected to boost the inclusion of AI in medical writing.
  • Growing volume of medical data: The ever-growing medical data from electronic health records to clinical research creates a strong demand for AI solutions that can process, organize, and interpret information efficiently. AI in medical writing helps to filter complex data into clear and compliant documentation, enhancing the ability to leverage big data for medical insights, patient care, and regulatory compliance. These factors are anticipated to drive the AI in medical writing market growth significantly.

Challenges

  • High initial investment costs: Companies need to invest significantly in technology infrastructure, AI model training, and customization for medical writing tasks. For smaller pharmaceutical firms or healthcare providers, these costs can be a barrier to adoption. Additionally, ongoing maintenance and upgrades to keep up with regulatory challenges and AI advancements add to the financial burden, slowing down the wider penetration of AI in medical writing market.
  • Data privacy and security concerns: Medical writing often involves sensitive patient data and proprietary clinical information. Ensuring compliance with global privacy regulations while using artificial intelligence systems can be complex. Players participating in the AI in medical writing market are required to implement robust cybersecurity measures to protect data from breaches and unauthorized access. The potential for AI-generated content to violate privacy regulations in documentation amplifies these concerns, requiring transparency in AI governance. 

Artificial Intelligence in Medical Writing Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

12.2%

Base Year Market Size (2025)

USD 878.08 million

Forecast Year Market Size (2035)

USD 2.78 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Artificial Intelligence in Medical Writing Market Segmentation:

 Deployment Mode Segment Analysis

Cloud-based segment is projected to capture AI in medical writing market share of over 57.7% by 2035. This is majorly due to its scalability, cost-effectiveness, and ease of access. The scalability is predominantly advantageous for variable workload handling related to medical writing, including clinical documentation or regulatory submissions volume fluctuations. Cloud-based deployment mode also supports real-time collaboration and data sharing by enabling seamless communication across various locations.

Additionally, the cloud often offers enhanced data security features, making it easier for companies to comply with strict privacy regulations while leveraging AI capabilities. In December 2023, Google Cloud launched MedLM, a generative AI regulated for the healthcare industry. The company further plans on bringing Gemini-based models into this suite, aiming to provide innovative capabilities in the upcoming years. Such developments are projected to boost the segment’s growth in the upcoming years, further boosting the market.

End use Segment Analysis

Based on end-use, the pharmaceutical and biotechnology companies segment is projected to register a considerable share in the AI in medical writing market during the forecast period. The growth is majorly due to the high demand for efficient clinical trial documentation, regulatory submissions, and research publications. These companies handle large volumes of complex data and require, precise, error-free reporting to comply with regulatory standards. AI tools streamline the process by automating tasks such as drafting clinical study reports, summarizing trial data, and generating regulatory documents.

In June 2024, TrialAssure launched TrialAssure LINK AI 2.0. The updated version is designed to assist pharmaceutical, and biotechnology companies, and clinical research organizations, in generating drafts of common regulatory and medical writing documents leveraging AI technology. These developments are projected to boost the market expansion significantly. The growing emphasis on innovation and faster time-to-market for new drugs further drives AI adoption in this sector, leading to expansion in the AI in medical writing market. 

Our in-depth analysis of the global market includes the following segments:

Type
  • Clinical writing
  • Regulatory writing
  • Patient documentation  
  • Scientific writing

Deployment Mode
  • Cloud-based
  • On-premises

End use
  • Pharmaceutical and biotechnology companies
  • Medical device companies
  • Academic and research institutes
  • Other end-users 
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Artificial Intelligence in Medical Writing Market Regional Analysis:

North America Market Insights

The AI in medical writing market in North America is on a significant growth trajectory, majorly driven by the region’s strong healthcare infrastructure, substantial R&D investments, and regulatory demands for accurate and timely medical documentation. Additionally, the need for cost-efficient operations in both pharmaceuticals and healthcare has spurred AI adoption to streamline ye documentation process. AI’s integration in medical writing has been supported by several big players in the AI and pharmaceutical industries, making North America a leader in the market.

The U.S. AI in medical writing is the largest market in North America, with growth primarily fueled by the high demand for efficient clinical trial documentation and the country’s extensive pharmaceutical and biotech industries. Machine learning models that enable NLP to simplify regulatory and clinical documentation are one of the key market drivers of the country. The U.S. market is hence projected to witness significant growth during the forecast period.

Canada AI in medical writing is rapidly evolving with a focus on bilingual documentation and localized regulatory requirements. AI’s role in patient engagement through personalized health summaries and automated insights that help clinicians in remote and underserved areas. The collaboration between Canadian tech firms and healthcare providers is also anticipated to drive innovation, particularly in tools designed for real-time patient data reporting.

APAC Market Insights

Asia Pacific AI in medical writing market is witnessing rapid growth owing to advancements in healthcare and technology. Key drivers include streamlined clinical trials regulatory compliance, and improving patient-centric documentation. Countries in the region are investing heavily in healthcare digitization, influenced by increasing demand for personalized medicines. Furthermore, the rise of electronic health records (EHRs) is encouraging AI integration into medical documentation further in the region. For instance, in January 2023, Fujitsu and Sapporo Medical University announced a partnership for a joint project for patients’ healthcare data including EHRs and PHRs.

India AI in medical writing is propelled by the country’s robust pharmaceutical and healthcare outsourcing industry, along with a surge in clinical research. Additionally, the Indian government's digital healthcare initiatives, such as the National Digital Health Mission, is fueling further AI adoption. Emerging trends include the deployment of ML for content generation in regulatory and clinical trial reports. Rising focus on quality and compliance with global standards, addressing both regional and international markets.

China AI in medical writing market is expanding greatly, driven by supporting government policies including Healthy China 2030. The China government is committed to technological advancements, along with a strong AI development ecosystem. As per the National Library of Medicine, in May 2019, AI technology is projected to transform the medical sector and trigger an estimated USD 147 billion market over the next 20 years. The market further focuses on integrating AI with big data analytics to create predictive and precision medical content.

AI in Medical Writing Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Artificial Intelligence in Medical Writing Market Players:

    AI in medical writing market companies are forming strategic partnerships with healthcare and pharmaceutical firms, developing specialized AI tools for regulatory compliance, and focusing on product innovation with custom AI models for medical documentation. The prominent players are also expanding globally, particularly in high-growth regions including APAC. Acquisitions of AI startups are common to enhance capabilities, while companies provide training and support services to ensure the smooth adoption of AI solutions in clinical trials and regulatory processes.

    • Artos
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • CureMetrix, Inc.
    • Epic Systems Corporation
    • Freyr
    • GENINVO
    • GNS Healthcare, Inc.
    • IBM Corporation
    • Parexel International (MA) Corporation
    • Pearson
    • TrialAssure
    • Trilogy Writing & Consulting GmbH  
    • Yseop 

Recent Developments

  • In July 2024, Yseop and Cognizant announced a collaboration to accelerate and scale the delivery of scientific content, by leveraging its medical writing functionalities, in the biopharma industry through generative AI.
  • In June 2024, Certara, Inc. launched its next-generation CoAuthor regulatory writing software, a platform designed for medical writers.  The platform combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools.
  • Report ID: 6614
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of artificial intelligence in medical writing is assessed at USD 974.49 million.

The global artificial intelligence in medical writing market size surpassed USD 878.08 million in 2025 and is projected to witness a CAGR of over 12.2%, crossing USD 2.78 billion revenue by 2035.

North America artificial intelligence (AI) in medical writing market will account for 39.20% share by 2035, driven by the region’s strong healthcare infrastructure, substantial R&D investments, and regulatory demands for accurate and timely medical documentation.

Key players in the market include IBM Corporation, Google LLC, Microsoft Corporation, OpenAI, Inc., Linguamatics (IQVIA), Nuance Communications, Inc. (Microsoft), Health Fidelity (Edifecs), Clinithink Ltd., Saama Technologies, Inc., Narrative Science (Tableau/Salesforce).

AI in Medical Writing Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Preeti Wani
Preeti Wani
Assistant Research Manager
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos